Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Gonzalez Rodriguez

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Revue Medicale Suisse|July 21, 2017
[Phosphocalcic anomalies and bone fragility keys for the general practitioner]Bérengère Aubry-Rozier, Delphine Stoll, Elena Gonzalez-Rodriguez
The Journal of Clinical Endocrinology and Metabolism|March 31, 2017
Response to the Letter by TrovasOlivier Lamy, Elena Gonzalez-Rodriguez, Bérengère Aubry-Rozier
Aging Clinical and Experimental Research|March 7, 2025
Denosumab for osteoporosis treatment: when, how, for whom, and for how long. A pragmatical approachOlivier Lamy, Judith Everts-Graber, Elena Gonzalez Rodriguez
Revue Medicale Suisse|January 20, 2022
[Osteoporosis]Elena Gonzalez Rodriguez, Anne-Cécile Debrach-Schneider, Olivier Lamy
Frontiers in Endocrinology|March 12, 2026
Atypical femoral fracture and jaw osteonecrosis under high doses of denosumab, healed with the aid of low dose of denosumab: a case reportHanene Lassoued, Olivier Lamy, Cyril Francioli, et al.
Revue Medicale Suisse|March 23, 2023
[Systemic mastocytosis and bone impact]Marie Vaucher, Elena Gonzalez Rodriguez, Anna Efthymiou, et al.
Revue Medicale Suisse|April 21, 2021
[Towards an individualized bone health report focused on the patient - Bone parameters and treatment options]Enisa Shevroja, Olivier Lamy, Elena Gonzalez Rodriguez, et al.
Frontiers in Endocrinology|November 10, 2025
Case Report: Increased FGF23 and new insufficiency fractures at burosumab discontinuation in X-linked hypophosphatemiaRobert Bandir, Laura Zanisi, Marie Nicod-Lalonde, et al.
Revue Medicale Suisse|July 21, 2017
[Denosumab in clinical practice : beware before, during and after]Olivier Lamy, Elena Gonzalez-Rodriguez, Delphine Stoll, et al.
The Lancet. Oncology|May 3, 2019
Denosumab in early-stage breast cancerElena Gonzalez Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Revue Medicale Suisse|July 21, 2017
[Phosphocalcic anomalies and bone fragility keys for the general practitioner]Bérengère Aubry-Rozier, Delphine Stoll, Elena Gonzalez-Rodriguez
The Journal of Clinical Endocrinology and Metabolism|March 31, 2017
Response to the Letter by TrovasOlivier Lamy, Elena Gonzalez-Rodriguez, Bérengère Aubry-Rozier
Aging Clinical and Experimental Research|March 7, 2025
Denosumab for osteoporosis treatment: when, how, for whom, and for how long. A pragmatical approachOlivier Lamy, Judith Everts-Graber, Elena Gonzalez Rodriguez
Revue Medicale Suisse|January 20, 2022
[Osteoporosis]Elena Gonzalez Rodriguez, Anne-Cécile Debrach-Schneider, Olivier Lamy
Frontiers in Endocrinology|March 12, 2026
Atypical femoral fracture and jaw osteonecrosis under high doses of denosumab, healed with the aid of low dose of denosumab: a case reportHanene Lassoued, Olivier Lamy, Cyril Francioli, et al.
Revue Medicale Suisse|March 23, 2023
[Systemic mastocytosis and bone impact]Marie Vaucher, Elena Gonzalez Rodriguez, Anna Efthymiou, et al.
Revue Medicale Suisse|April 21, 2021
[Towards an individualized bone health report focused on the patient - Bone parameters and treatment options]Enisa Shevroja, Olivier Lamy, Elena Gonzalez Rodriguez, et al.
Frontiers in Endocrinology|November 10, 2025
Case Report: Increased FGF23 and new insufficiency fractures at burosumab discontinuation in X-linked hypophosphatemiaRobert Bandir, Laura Zanisi, Marie Nicod-Lalonde, et al.
Revue Medicale Suisse|July 21, 2017
[Denosumab in clinical practice : beware before, during and after]Olivier Lamy, Elena Gonzalez-Rodriguez, Delphine Stoll, et al.
The Lancet. Oncology|May 3, 2019
Denosumab in early-stage breast cancerElena Gonzalez Rodriguez, Bérengère Aubry-Rozier, Delphine Stoll, et al.
Pageof 8